Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this ascending-dose research study is to determine whether the administration
of ARC1779 Injection improves subject's health profile by protecting the brain, heart, and
kidney from damage due to formation of small blood clots in blood vessels. It will also
determine the safety of ARC1779 Injection, how ARC1779 Injection enters and leaves the blood
and tissue over time, and its effect on laboratory tests related to blood clotting, heart and
brain function, and other body systems.